Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06771531 · ClinicalTrials.gov registry record · NA

Brain Stimulation for Foot-sole Sensation in Older Adults With Foot-sole Somatosensory Deficits

A NA study of Mobility and Somatosensory Function, sponsored by Hebrew SeniorLife.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06771531: Recruiting NA study of Mobility and Somatosensory Function, sponsored by Hebrew SeniorLife.

NCT06771531 is a NA study of Mobility and Somatosensory Function that is actively recruiting participants, run by Hebrew SeniorLife. The registered enrollment target is 20 participants, below the 61-participant average among 3 other Mobility trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06771531, a NA study of Mobility and Somatosensory Function, is actively recruiting participants, sponsored by Hebrew SeniorLife.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

In older adults, diminished sensation of the legs and feet is highly prevalent and causes poor balance and reduced mobility. This type of sensation is not only dependent upon the receptors and nerves in the legs and feet, but also upon a complex central nervous system pathway that includes the cerebral cortex of the brain. This project will use a form of noninvasive brain stimulation called transcranial direct current stimulation (tDCS) to test whether increasing the excitability of the brain networks that process sensory feedback can augment foot sole sensation, balance, and mobility in older adults suffering from mild-to-moderate foot sole sensory impairments.

Primary Outcome

This metric assesses the degree to which the soft support and cut-off of the vision diminishes the control of standing posture.

Interventions

  • DEVICE transcranial direct current stimulation
  • DEVICE active sham stimulation

Study Locations (1)

Massachusetts

  • Hebrew SeniorLife - Roslindale

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2026-03-09
Est. Completion 2026-12-31
Phase NA
Hebrew SeniorLife

32 total trials

What NCT06771531 shows while recruiting

NCT06771531 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 61-participant average among 3 other Mobility trials with a reported enrollment target (67% lower).

The record links to 3 conditions, with Mobility appearing as the primary indexed condition, and to 2 interventions - of which transcranial direct current stimulation is the first listed.

NCT06771531 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06771531 about?

NCT06771531 is a clinical study titled "Brain Stimulation for Foot-sole Sensation in Older Adults With Foot-sole Somatosensory Deficits". In older adults, diminished sensation of the legs and feet is highly prevalent and causes poor balance and reduced mobility. This type of sensation is not only dependent upon the receptors and nerves in the legs and feet, but also upon a complex central nervous system pathway that includes the cereb...

What is the current status of trial NCT06771531?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-03-09. Estimated completion is 2026-12-31.

What conditions does trial NCT06771531 study?

This clinical trial studies the following conditions: Mobility, Somatosensory Function, Balance Control.

What interventions are being tested in trial NCT06771531?

The interventions under investigation include: transcranial direct current stimulation (DEVICE), active sham stimulation (DEVICE).

Who is sponsoring clinical trial NCT06771531?

This trial is sponsored by Hebrew SeniorLife, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06771531 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mobility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06771531, the US trial registry maintained by the National Library of Medicine. NCT06771531 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.